World Health Organization. Global health sector strategy on viral hepatitis 2016–2021, towards ending viral hepatitis. Geneva: WHO; 2016.

Google Scholar 

World Health Organization. Guidelines on hepatitis B and C testing. Geneva. Switzerland: World Health Organization; 2017. p. 2017.

Google Scholar 

Kuo YH, Chang KC, Wang JH, et al. Is hepatitis C virus core antigen an adequate marker for community screening? J Clin Microbiol. 2012;50:1989–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghany MG, Strader DB, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. Diagnosis management, and treatment of hepatitis C: an update. Hepatology. 2009;49:1335–74.

Centers for Disease Control and Prevention. Guidelines for laboratory testing and result reporting. 2013. http://www.cdc.gov/hepatitis/hcv/labtesting.htm. Accessed 20 December 2022

Centers for Disease Control and Prevention. Guidelines for laboratory testing and result reporting. MMWR Morb Mortal 2013;62:362–5. http://www.cdc.gov/mmwr/pdf/wk/mm62e0507a2.pdf. Accessed 20 December 2022

WHO. Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection. Update version. 2018. https://www.who.int/publications/i/item/9789241550345. Accessed 20 December 2022

Arboledas JCA, Guerrero IP, Rodríguez MJB, et al. Hepatitis C virus core antigen in the management of patients treated with new direct-acting antivirals. Diagn Microbiol Infect Dis. 2017;89:29–34.

Article  CAS  PubMed  Google Scholar 

Galli C, Julicher P, Plebani M. HCV core antigen comes of age: a new opportunity for the diagnosis of hepatitis C virus infection. Clin Chem Lab Med. 2018;56:880–8.

Article  CAS  PubMed  Google Scholar 

Benito R, Arribas J, Algarate S, Cebollada R, Gude MJ. Hepatitis C virus core antigen for screening organ donors and recipients. Diagn Microbiol Infect Dis. 2018;91:126–9.

Article  CAS  PubMed  Google Scholar 

Wang Y, Jie W, Ling J, Yuanshuai H. HCV core antigen plays an important role in the fight against HCV as an alternative to HCV-RNA detection. J Clin Lab Anal. 2021;35:e23755.

Central Bureau of Health Intelligence (2016) Ministry of Health and Family Welfare. National Health Profile. New Delhi, India. https://cbhidghs.mohfw.gov.in/index.

National guidelines for Diagnosis and Management of Viral Hepatitis. Ministry of Health and family welfare, Government of India. National Viral Hepatitis Control Program (NVHCP) National Health Portal Of India. 2018. Accessed  3/4/2023

Alonso R, Pérez-García F, López-Roa P, Alcalá L, Rodeño P, Bouza E.  HCV core-antigen assay as an alternative to HCV RNA quantification: a correlation study for the assessment of HCV viremia. Enferm Infecc Microbiol Clin (Engl Ed). 2018;36:175–8.

Rebucci C, Cerino A, Cividini A, Timo L, Furione M, Mondelli MU. Monitoring response to antiviral therapy for patients with chronic hepatitis C virus infection by a core-antigen assay. J Clin Microbiol. 2003;41:3881–4.

Ponnuvel S, Fletcher GJ, Anantharam R, Varughese S, David VG, Abraham P. Clinical utility of hepatitis C virus core antigen (HCVcAg) assay to identify active HCV infection in hemodialysis and renal transplant patients. PLoS One. 2021;16:e0250263.

Solitano V, Plaz Torres MC, Pugliese N, Aghemo A. Management and treatment of hepatitis C: are there still unsolved problems and unique populations? Viruses. 2021;13:1048. https://doi.org/10.3390/v13061048.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harrison GL, Pryor J, Malani J, et al. Infection frequency of hepatitis C virus and IL28B haplotypes in Papua New Guinea, Fiji, and Kiribati. PLoS One. 2013;8:e66749.

Mateos P. Names, ethnicity and populations; tracing identity in space. Heidelberg: Springer; 2014.

Mateos P. A review of name-based ethnicity classification methods and their potential in population studies. Popul Space Place. 2007;13:243–63.

Article  Google Scholar 

Kumbhar N, Ramachandran K, Kumar G, Rao Pasupuleti SS, Sharma MK, Gupta E. Utility of hepatitis C virus core antigen testing for diagnosis and treatment monitoring in HCV infection: a study from India. Indian J Med Microbiol. 2021;39(4):462–6.

Article  CAS  PubMed  Google Scholar 

Kannan A, Biswas L, Kumar A, et al. Improving diagnosis of hepatitis C virus infection using hepatitis C core antigen testing in a resource-poor setting. Rev Soc Bras Med Trop. 2021;10:54.

Reddy AK, Dakshinamurty KV, Lakshmi V. Utility of HCV core antigen ELISA in the screening for hepatitis C virus infection in patients on hemodialysis. Indian J Med Microbiol. 2006;24:55–7.

Article  CAS  PubMed  Google Scholar 

Medhi S, Potukuchi SK, Polipalli SK, et al. Diagnostic utility of hepatitis C virus core antigen in hemodialysis patients. Clin Biochem. 2008;41:447–52.

Article  CAS  PubMed  Google Scholar 

Patel J, Sharma P. Design of a novel rapid immunoassay for simultaneous detection of hepatitis C virus core antigen and antibodies. Adv Virol. 2020;165:627–41.

CAS  Google Scholar 

Shah H, Bilodeau M, Burak KW, et al. The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver. CMAJ. 2018;190:E677–87.

Article  PubMed  PubMed Central  Google Scholar 

Adland E, Jesuthasan G, Downs L, et al. Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort. BMC Infect Dis. 2018;18:461.

Article  PubMed  PubMed Central  Google Scholar 

Bertisch B, Brezzi M, Negro F, et al. Swiss Hepatitis C Cohort Study. 2020. Very low hepatitis C viral loads in treatment-naive persons: do they compromise hepatitis C virus antigen testing? Clin Infect Dis 70:653–9. https://doi.org/10.1093/cid/ciz270